Evidence map›Paper›PMID 35957160›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Breaking and Connecting: Highly Hazy and Transparent Regenerated Networked-Nanofibrous Cellulose Films via Combination of Hydrolysis and Crosslinking.

Jamaliah Aburabie, Raed Hashaikeh

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jamaliah AburabieNYUAD Water Research Center, Department of Engineering, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.ORCID 0000-0001-8944-1117
Raed HashaikehNYUAD Water Research Center, Department of Engineering, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.ORCID 0000-0002-0248-7495

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High optical transparency combined with high optical haze are essential requirements for optoelectronic substrates. Light scattering caused by haze is responsible for increasing light harvesting in photon-absorbing active materials, hence increasing efficiencies. A trade-off between transparency and haze is common in solar substrates with high transparency (~90%) and low optical haze (~20%), or vice versa. In this study, we report a novel, highly transparent film fabricated from regenerated cellulose after controlled acid-hydrolysis of microcrystalline cellulose (MCC). The developed networked-nanofibrous cellulose was chemically crosslinked with glutaraldehyde (GA) and vacuum-cured to facilitate the fabrication of mechanically stable films. The effects of crosslinker concentration, crosslinking time, and curing temperature were investigated. Optimum conditions for fabrication unveils high optical transparency (~94%) and high haze (~60%), using 25% GA for 24 hr with a curing temperature of 25 °C; therefore, conveying an optimal substrate for optoelectronics applications. The high haze arises primarily from the crystalline, networked crystals of cellulose II structure formed within the regenerated cellulose upon hydrolysis. Moreover, the developed crosslinked film presents high thermal stability, water resistance, and good mechanical resilience. This high-performance crosslinked cellulose film can be considered a potential material for new environmentally-friendly optical substrates.

Indexed as

cellulosecrosslinkinghazyhydrolysisoptoelectronicssolar cellstransparent

Identifiers

PMID35957160
PMCPMC9370136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.